Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019

Figures & data

Table 1. Incident cases and deaths due to bladder and urinary tract cancers and person-years per 100,000 in Nordic countries, 1990–2019.

Country	Sex	Measure	Age category, years					Total
			20–49	50–59	60–69	70–79	≥ 80
Denmark	Men	Incident cases	1,880	5,023	12,584	16,076	8,657	44,220
		Deaths	173	756	2,519	4,813	4,767	13,028
		Person-years (per 100,000)	354.13	108.45	85.94	55.15	23.82	627.49
	Women	Incident cases	680	1,948	4,302	5,516	3,703	16,149
		Deaths	104	342	1,013	1,945	2,455	5,859
		Person-years (per 100,000)	343.44	107.79	90.76	67.80	44.40	654.19
Finland	Men	Incident cases	990	2,500	6,188	8,389	5,369	23,436
		Deaths	75	342	1,100	1,994	2,336	5,847
		Person-years (per 100,000)	337.84	107.92	84.71	49.53	20.10	600.10
	Women	Incident cases	277	663	1,621	2,400	2,687	7,648
		Deaths	36	96	319	731	1,523	2,705
		Person-years (per 100,000)	324.05	108.69	94.35	70.81	45.62	643.51
Iceland	Men	Incident cases	89	171	418	493	340	1,511
		Deaths	6	25	72	124	157	384
		Person-years (per 100,000)	20.33	5.12	3.72	2.31	1.13	32.60
	Women	Incident cases	37	59	123	148	123	490
		Deaths	7	15	17	37	69	145
		Person-years (per 100,000)	19.45	5.00	3.76	2.62	1.70	32.54
Norway	Men	Incident cases	1,135	3,088	7,026	10,535	7,368	29,152
		Deaths	86	354	1,178	2,674	3,889	8,181
		Person-years (per 100,000)	313.09	87.49	67.63	45.16	21.69	535.05
	Women	Incident cases	408	1,024	2,310	3,336	3,308	10,386
		Deaths	62	162	458	1,021	2,062	3,765
		Person-years (per 100,000)	299.11	84.89	70.03	55.72	40.44	550.19
Sweden	Men	Incident cases	1,892	5,160	13,718	21,013	13,979	55,762
		Deaths	142	725	2,351	5,452	7,157	15,827
		Person-years (per 100,000)	582.54	178.32	148.08	104.36	51.82	1,065.11
	Women	Incident cases	742	1,862	4,552	6,872	6,098	20,126
		Deaths	103	308	881	2,172	3,964	7,428
		Person-years (per 100,000)	558.51	175.21	153.78	124.43	90.29	1,102.21

Figure 1. Age-standardized incidence rate for bladder and urinary tract cancers in Nordic countries per 100,000 (adjusted for the World Standard Population) in (A) men and (B) women, 1990–2019.

Table 2. Rate ratios comparing incidence and mortality rates for bladder and urinary tract cancers in Nordic countries in men (reference) and women, 1990–2019.

Country	Sex	Incidence		Mortality
		IRR (95% CI)	Trend (95% CI)	MRR (95% CI)	Trend (95% CI)
Denmark	Men	Ref	0.997 (0.996–0.998)	Ref	0.976 (0.975–0.978)
	Women	0.291 (0.286–0.296)	1.003 (1.001–1.005)	0.312 (0.303–0.322)	0.990 (0.988–0.993)
Finland	Men	Ref	0.997 (0.995–0.998)	Ref	0.984 (0.981–0.987)
	Women	0.219 (0.213–0.224)	0.999 (0.996–1.001)	0.261 (0.249–0.274)	0.988 (0.984–0.992)
Iceland	Men	Ref	1.001 (0.995–1.006)	Ref	0.999 (0.988–1.011)
	Women	0.280 (0.253–0.311)	0.996 (0.986–1.006)	0.295 (0.244–0.358)	0.984 (0.966–1.002)
Norway	Men	Ref	1.003 (1.002–1.005)	Ref	0.987 (0.984–0.989)
	Women	0.274 (0.268–0.281)	1.011 (1.009–1.013)	0.299 (0.288–0.311)	0.989 (0.985–0.993)
Sweden	Men	Ref	1.003 (1.002–1.004)	Ref	0.996 (0.994–0.998)
	Women	0.287 (0.282–0.292)	1.007 (1.006–1.009)	0.326 (0.317–0.335)	1.001 (0.999–1.004)

Trends in incidence and mortality rates are presented as annual change. Sex-specific IRR and MRR were adjusted for age categories and a natural cubic spline for period effects. Trend estimates were adjusted for age categories in sex strata.

IRR: incidence rate ratio; MRR: mortality rate ratio; Ref: reference.

Figure 2. Age-standardized mortality rate for bladder and urinary tract cancers in Nordic countries per 100,000 (adjusted for the World Standard Population) in (A) men and (B) women, 1990–2019.

Figure 3. Five-year relative survival for bladder and urinary tract cancers in Nordic countries in (A) men and (B) women, 1990–2019.

Data availability statement

A public database was used as the source of data and all data are available at the website (https://nordcan.iarc.fr/en). Please see the Methods section for details.